Reduced expression of bone morphogenetic protein receptor IA in pancreatic cancer is associated with a poor prognosis

BACKGROUND: The expression of SMAD4, the central component of the transforming growth factor-β (TGF-β) and bone morphogenetic protein (BMP) signalling pathways, is lost in 50% of pancreatic cancers and is associated with a poor survival. Although the TGF-β pathway has been extensively studied and ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Voorneveld, P W, Stache, V, Jacobs, R J, Smolders, E, Sitters, A I, Liesker, A, S Korkmaz, K, Lam, S M, De Miranda, N F C C, Morreau, H, Kodach, L L, Hardwick, J C H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790157/
https://www.ncbi.nlm.nih.gov/pubmed/23969729
http://dx.doi.org/10.1038/bjc.2013.486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790157/
https://www.ncbi.nlm.nih.gov/pubmed/23969729
http://dx.doi.org/10.1038/bjc.2013.486

Ejemplares similares